| CAS No 37951-12-5 |
(1E,4E)-1,5-BIS(4-METHOXYPHENYL)PENTA-1,4-DIEN-3-ONEnull |
Inquiry |
| CAS No 16136-85-9 |
(1E)-1-CHLOROPROP-1-ENEnull |
Inquiry |
| CAS No 136329-39-0 |
(1-PHENYL-2-PYRROLIDINYLETHYL)METHYLAMINEnull |
Inquiry |
| CAS No 879896-47-6 |
(1-METHYL-5-THIEN-2-YL-1H-PYRAZOL-3-YL)METHANOL 97%null |
Inquiry |
| CAS No 879896-49-8 |
(1-METHYL-3-THIEN-2-YL-1H-PYRAZOL-5-YL)METHANOL 97%null |
Inquiry |
| CAS No 898289-09-3 |
(1-METHYL-3-THIEN-2-YL-1H-PYRAZOL-5-YL)METHYLAMINE 97%null |
Inquiry |
| CAS No 1578-96-7 |
(1-METHYL-1H-INDAZOL-3-YL)METHANOL 97%null |
Inquiry |
| CAS No 98412-23-8 |
(1-BENZYL-2-SULPHANYL-1H-IMIDAZOL-5-YL)METHANOLnull |
Inquiry |
| CAS No 120321-72-4 |
(1-METHYL-1H-1,2,3-BENZOTRIAZOL-5-YL)METHANOLnull |
Inquiry |
| CAS No 34570-16-6 |
(1,3-DIETHOXY-3-OXOPROP-1-ENYL)AMMONIUM CHLORIDEnull |
Inquiry |
| CAS No 56278-50-3 |
(1,3-BENZOTHIAZOL-2-YL)ACETONITRILEnull |
Inquiry |
| CAS No 352018-93-0 |
(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)METHYLAMINEnull |
Inquiry |
| CAS No 109887-53-8 |
()-TRANS-4-(4-FLUOROPHENYL)-3-HYDROXYMETHYL- 1-METHYLPIPERIDINE 98%null |
Inquiry |
| CAS No 93-52-7 |
(1,2-DIBROMOETHYL)BENZENEnull |
Inquiry |
| CAS No 109887-52-7 |
()-TRANS-3-ETHOXYCARBONYL-4-(4-FLUOROPHEYL)- 1-METHYLPIPERIDINE-2,6-DIONE 98%null |
Inquiry |
| CAS No 78628-80-5 |
({[(2E)-6,6-DIMETHYLHEPT-2-EN-4-YN-1-YL](METHYL)AMINO}METHYL)NAPHTHALENE HYDROCHLORIDEnull |
Inquiry |
| CAS No 655-48-1 |
()-HYDROBENZOINnull |
Inquiry |
| CAS No 105812-81-5 |
(-)-TRANS-4-(4''-FLUOROPHENYL)-3-HYDROXYMETHYL-1-METHYLPIPERIDINEnull |
Inquiry |
| CAS No 469-23-8 |
(-)-ESERETHOLEnull |
Inquiry |
| CAS No 62708-56-9 |
(-)-O,O''-DIBENZOYL-L-TARTARIC ACID HYDRATEnull |
Inquiry |
| CAS No 485-71-2 |
(-)-CINCHONIDINEnull |
Inquiry |
| CAS No 13429-83-9 |
(-)-CAMPHANIC ACIDnull |
Inquiry |
| CAS No 148461-14-7 |
(-)(4S)-2-[2-(DIPHENYLPHOSPHINO)PHENYL]-4-(2-PROPYL)OXAZOLINE 97%null |
Inquiry |
| CAS No 492-37-5 |
(+/-)-2-PHENYLPROPANOIC ACIDnull |
Inquiry |
| CAS No 94105-90-5 |
(+/-)-7-HYDROXY-3-(4-HYDROXYPHENYL)CHROMANnull |
Inquiry |
